Package 25021-798-10

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "20212ecb-248d-4fc6-b88d-c54a18076845", "openfda": {"unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670200"], "spl_set_id": ["e1dab8ad-cbf6-4273-92fa-02629de2abde"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-798-02)  / 2 mL in 1 VIAL", "package_ndc": "25021-798-02", "marketing_start_date": "20250115"}, {"sample": false, "description": "10 VIAL in 1 CARTON (25021-798-10)  / 10 mL in 1 VIAL", "package_ndc": "25021-798-10", "marketing_start_date": "20250115"}], "brand_name": "Fosphenytoin Sodium", "product_id": "25021-798_20212ecb-248d-4fc6-b88d-c54a18076845", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "25021-798", "generic_name": "Fosphenytoin Sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin Sodium", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA214926", "marketing_category": "ANDA", "marketing_start_date": "20250115", "listing_expiration_date": "20261231"}